336 related articles for article (PubMed ID: 15570901)
1. [Two cases of autosomal dominant polycystic kidney diseases who presented bilateral enlarged kidneys and severe hypertension in the neonatal period].
Wakaki H; Ikeda M; Hataya H; Ishikura K; Nakashima T; Oosako Y; Honda M
Nihon Jinzo Gakkai Shi; 2004 Oct; 46(7):719-23. PubMed ID: 15570901
[TBL] [Abstract][Full Text] [Related]
2. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
Kelleher CL; McFann KK; Johnson AM; Schrier RW
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
[TBL] [Abstract][Full Text] [Related]
4. Congenital hepatic fibrosis in a child with autosomal dominant polycystic kidney disease.
Kanaheswari Y; Hamzaini AH; Wong SW
Med J Malaysia; 2008 Aug; 63(3):251-3. PubMed ID: 19248702
[TBL] [Abstract][Full Text] [Related]
5. Progress in blood pressure control in autosomal dominant polycystic kidney disease.
Ecder T; Edelstein CL; Fick-Brosnahan GM; Johnson AM; Duley IT; Gabow PA; Schrier RW
Am J Kidney Dis; 2000 Aug; 36(2):266-71. PubMed ID: 10922304
[TBL] [Abstract][Full Text] [Related]
6. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
Lawson CR; Doulton TW; MacGregor GA
J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
[TBL] [Abstract][Full Text] [Related]
7. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
Schrier RW
J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
[TBL] [Abstract][Full Text] [Related]
8. Expression of components of the renin-angiotensin system in autosomal recessive polycystic kidney disease.
Loghman-Adham M; Soto CE; Inagami T; Sotelo-Avila C
J Histochem Cytochem; 2005 Aug; 53(8):979-88. PubMed ID: 15879580
[TBL] [Abstract][Full Text] [Related]
9. Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications.
Taylor M; Johnson AM; Tison M; Fain P; Schrier RW
Am J Kidney Dis; 2005 Sep; 46(3):415-23. PubMed ID: 16129202
[TBL] [Abstract][Full Text] [Related]
10. The neonate with adult-type autosomal dominant polycystic kidney disease.
Chevalier RL; Garland TA; Buschi AJ
Int J Pediatr Nephrol; 1981 Jun; 2(2):73-7. PubMed ID: 7341536
[TBL] [Abstract][Full Text] [Related]
11. Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.
De Almeida EA; Prata MM
Rev Port Cardiol; 2007 Nov; 26(11):1173-82. PubMed ID: 18297839
[TBL] [Abstract][Full Text] [Related]
12. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.
Christophe JL; van Ypersele de Strihou C; Pirson Y
Nephrol Dial Transplant; 1996 Jul; 11(7):1271-6. PubMed ID: 8672022
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of autosomal dominant polycystic kidney disease treated with hemodialysis associated with polycystic liver complications related to the cause of death].
Saima S; Suzuki Y; Yoshimoto K; Nakamura Y; Munakata A
Nihon Jinzo Gakkai Shi; 1996 Jun; 38(6):278-84. PubMed ID: 8752971
[TBL] [Abstract][Full Text] [Related]
14. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
Barendregt JN; Florijn KW; Muizert Y; Chang PC
Nephrol Dial Transplant; 1995; 10(8):1332-41. PubMed ID: 8538923
[TBL] [Abstract][Full Text] [Related]
15. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
[TBL] [Abstract][Full Text] [Related]
16. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
17. Chronic renal failure in a patient with Sotos syndrome due to autosomal dominant polycystic kidney disease.
Cefle K; Yildiz A; Palanduz S; Ozturk S; Ozbey N; Kylyçaslan I; Colakoglu S; Balci C
Int J Clin Pract; 2002 May; 56(4):316-8. PubMed ID: 12074220
[TBL] [Abstract][Full Text] [Related]
18. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
Miller RH; Lehmkuhl LB; Smeak DD; DiBartola SP; Radin J
Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161
[TBL] [Abstract][Full Text] [Related]
19. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
Masoumi A; Elhassan E; Schrier RW
Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
[TBL] [Abstract][Full Text] [Related]
20. Experience with autosomal dominant polycystic kidney disease in patients before and after renal transplantation: a 7-year observation.
Sulikowski T; Tejchman K; Zietek Z; Rózański J; Domański L; Kamiński M; Sieńko J; Romanowski M; Nowacki M; Pabisiak K; Kaczmarczyk M; Ciechanowski K; Ciechanowicz A; Ostrowski M
Transplant Proc; 2009; 41(1):177-80. PubMed ID: 19249508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
